Skip to main content
Welcome to
super saver spring
offer ends april 20
save over $140
Sale ends in
per week for 24 weeks
Welcome to
super saver spring
per week for 24 weeks
save over $140
// //

Sernova Corp TSX Venture: SVA-X

Today's Change
Real-Time Last Update TSX Venture Last Sale

Today's Trading

Day Low 1.430
Day High 1.490
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. It develops a commercially-viable treatment for insulin-dependent human diabetes and other metabolic, blood, and neurological diseases with therapeutic cells placed into its implanted, prevascularized and scalable medical device.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Moderate Buy


A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.


What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.


A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Sernova Appoints Internationally Renowned Thyroid Disease Expert Dr. Sam Wiseman to its Scientific Advisory Board
- - Wed Apr 14, 8:00AM CDT - CMTX
Wed Apr 14, 8:00AM CDT
(via TheNewswire)
Sernova Announces Presentation at the American Diabetes Association 81st Scientific Sessions
- - Tue Apr 6, 8:03AM CDT - CMTX
Tue Apr 6, 8:03AM CDT
(via TheNewswire)
Sernova's Story Front-Page Nationally via Canada's Largest Newspaper Independent
- - Tue Mar 23, 8:01AM CDT - CMTX
Tue Mar 23, 8:01AM CDT
(via TheNewswire)
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 1.400 +5.00% increase
on 03/29/21
Period Open:1.560
Price movement based on the high, low and last over the given period.
1.670 -11.98% decrease
on 03/23/21
-0.090 (-5.77%) decrease
since 03/19/21
3-Month 1.160 +26.72% increase
on 02/01/21
Period Open:1.750
Price movement based on the high, low and last over the given period.
2.180 -32.57% decrease
on 02/08/21
-0.280 (-16.00%) decrease
since 01/20/21
52-Week 0.135 +988.89% increase
on 05/04/20
Period Open:0.130
Price movement based on the high, low and last over the given period.
2.870 -48.78% decrease
on 01/19/21
+1.340 (+1,030.77%) increase
since 04/20/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies